Pharmaceutical Product Registration Requirements in ASEAN & CIS Countries
DOI:
https://doi.org/10.37591/rrjodfdp.v1i2.311Abstract
The Association of Southeast Asian Nations (ASEAN) and the Commonwealth of Independent States (CIS) nations are two of the emerging pharmaceutical markets. There is a rise in income levels of middle class, rise in health consciousness and growing burden of disease among the aged groups which has led to an increased demand for general and lifesaving medicines in the emerging pharmaceutical markets. This paper approaches the pharmaceutical product registration requirements in ASEAN and CIS countries. Diversity of regulatory requirements is noticed among the two regions; hence it is difficult to obtain marketing approval for pharmaceuticals at the same time in these nations because of unnecessary duplication of work, waste of valuable resources etc. Further attempts needs to be carried out globally to harmonise regulations so that the drug approval process becomes easy and duplication of work and waste of valuable resources is avoided.
Keywords: ASEAN, CIS, CTD, ACTD, harmonisation
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |